Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-000659
Filing Date
2025-02-05
Accepted
2025-02-05 16:18:10
Documents
101
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q pahc-20241231x10q.htm   iXBRL 10-Q 2555580
2 EX-31.1 pahc-20241231xex31d1.htm EX-31.1 8059
3 EX-31.2 pahc-20241231xex31d2.htm EX-31.2 8029
4 EX-32.1 pahc-20241231xex32d1.htm EX-32.1 3782
5 EX-32.2 pahc-20241231xex32d2.htm EX-32.2 4052
  Complete submission text file 0001558370-25-000659.txt   10648669

Data Files

Seq Description Document Type Size
6 EX-101.SCH pahc-20241231.xsd EX-101.SCH 68818
7 EX-101.CAL pahc-20241231_cal.xml EX-101.CAL 91716
8 EX-101.DEF pahc-20241231_def.xml EX-101.DEF 354893
9 EX-101.LAB pahc-20241231_lab.xml EX-101.LAB 490449
10 EX-101.PRE pahc-20241231_pre.xml EX-101.PRE 543059
104 EXTRACTED XBRL INSTANCE DOCUMENT pahc-20241231x10q_htm.xml XML 2026057
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36410 | Film No.: 25593548
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)